DK0394136T3 - Bakteriestammer af slægten Bifidobacterium med IgA induktionspotentiale - Google Patents

Bakteriestammer af slægten Bifidobacterium med IgA induktionspotentiale

Info

Publication number
DK0394136T3
DK0394136T3 DK90401072.5T DK90401072T DK0394136T3 DK 0394136 T3 DK0394136 T3 DK 0394136T3 DK 90401072 T DK90401072 T DK 90401072T DK 0394136 T3 DK0394136 T3 DK 0394136T3
Authority
DK
Denmark
Prior art keywords
iga
induction potential
strains
present
potential
Prior art date
Application number
DK90401072.5T
Other languages
English (en)
Inventor
Hisako Yasui
Kazuhito Hayakawa
Makoto Ohwaki
Tatsuhiko Kan
Original Assignee
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Kk filed Critical Yakult Honsha Kk
Application granted granted Critical
Publication of DK0394136T3 publication Critical patent/DK0394136T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK90401072.5T 1989-04-21 1990-04-20 Bakteriestammer af slægten Bifidobacterium med IgA induktionspotentiale DK0394136T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1100282A JPH07106142B2 (ja) 1989-04-21 1989-04-21 ＩｇＡ誘導能を有するビフィドバクテリウム・ロンガム又はビフィドバクテリウム・ブレーベ

Publications (1)

Publication Number Publication Date
DK0394136T3 true DK0394136T3 (da) 1996-01-02

Family

ID=14269841

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90401072.5T DK0394136T3 (da) 1989-04-21 1990-04-20 Bakteriestammer af slægten Bifidobacterium med IgA induktionspotentiale

Country Status (12)

Country Link
US (1) US5192685A (da)
EP (1) EP0394136B1 (da)
JP (1) JPH07106142B2 (da)
KR (1) KR0170374B1 (da)
AT (1) ATE130101T1 (da)
AU (1) AU643683B2 (da)
CA (1) CA2014826C (da)
DE (1) DE69023384T2 (da)
DK (1) DK0394136T3 (da)
ES (1) ES2078954T3 (da)
GR (1) GR3018695T3 (da)
NZ (1) NZ233365A (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3269890B2 (ja) * 1993-08-25 2002-04-02 株式会社ヤクルト本社 ワクチンの効果増強剤及び効果増強食品
JPH0827011A (ja) * 1994-07-12 1996-01-30 Yakult Honsha Co Ltd 胎児定着増強剤及び母動物用食
TW357191B (en) * 1996-06-04 1999-05-01 Food Industry Development Res Institute Bifidobacteria strains with acid, bile salt and oxygen tolerance and their culture method the invention relates to bifidobacteria strains with acid, bile salt and oxygen tolerance and their culture method
US6306638B1 (en) 1996-10-22 2001-10-23 Food Industry Research And Development Institute Mutant bifidobacteria strains with acid, bile salt and oxygen tolerance
US6146411A (en) * 1998-12-24 2000-11-14 Alsius Corporation Cooling system for indwelling heat exchange catheter
KR101234435B1 (ko) 2005-02-02 2013-02-18 가부시키가이샤 메이지 면역 부활용 조성물
JP2006298783A (ja) * 2005-04-18 2006-11-02 Nisshin Sugar Mfg Co Ltd 免疫賦活組成物
EP1723965A1 (en) 2005-05-18 2006-11-22 Stallergenes Sa Compositions for antigen-specific induction of immuno-tolerance via oral immunization
NZ577767A (en) 2006-12-21 2012-04-27 Calpis Co Ltd Use of Lactobacillus amylovorus cells in the manufacture of a medicament for improving or preventing periodontal disease by promoting IGA production
JP5936392B2 (ja) 2012-03-02 2016-06-22 松谷化学工業株式会社 ＩｇＡ産生促進剤
JP2022132724A (ja) * 2021-03-01 2022-09-13 国立研究開発法人農業・食品産業技術総合研究機構 免疫グロブリンａ分泌促進剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3120505C2 (de) * 1981-05-22 1986-04-24 EVOG - Etablissement für Verwaltung und Organisation, Balzers Verfahren zum Herstellen von stichfesten Sauermilchprodukten
JPS59118712A (ja) * 1982-12-27 1984-07-09 Morinaga Milk Ind Co Ltd 抗腫瘍剤及びその製造法
JPS59135883A (ja) * 1983-01-23 1984-08-04 Yakult Honsha Co Ltd ビフイドバクテリウム属の細菌のプロトプラスト調製方法
US4717654A (en) * 1984-06-19 1988-01-05 Akzo N.V. Process for solid phase platelet antibody assay
JPS61257930A (ja) * 1985-05-09 1986-11-15 Morinaga Milk Ind Co Ltd 感染防御剤

Also Published As

Publication number Publication date
EP0394136A3 (en) 1992-10-07
GR3018695T3 (en) 1996-04-30
EP0394136A2 (en) 1990-10-24
US5192685A (en) 1993-03-09
EP0394136B1 (en) 1995-11-08
JPH07106142B2 (ja) 1995-11-15
DE69023384T2 (de) 1996-04-25
CA2014826A1 (en) 1990-10-21
JPH02280059A (ja) 1990-11-16
DE69023384D1 (de) 1995-12-14
KR900016470A (ko) 1990-11-13
NZ233365A (en) 1992-09-25
AU643683B2 (en) 1993-11-25
ES2078954T3 (es) 1996-01-01
ATE130101T1 (de) 1995-11-15
CA2014826C (en) 1999-06-15
KR0170374B1 (ko) 1999-02-01
AU5372890A (en) 1990-10-25

Similar Documents

Publication Publication Date Title
DK0394136T3 (da) Bakteriestammer af slægten Bifidobacterium med IgA induktionspotentiale
EP0077734A3 (en) Production of monoclonal antibodies against bacterial adhesins
DE59209650D1 (de) Monoklonale antikörper gegen c-kit
ATE13741T1 (de) Ein spezifisches antigen enthaltender impfkomplex und ihn enthaltender impfstoff.
ES2097808T3 (es) Anticuerpos de marco conservado mutado y su preparacion.
FI904345A0 (fi) Syntetisk peptidantigen foer detektering av htlv-1 infektion.
IT8547624A0 (it) Ceppi batterici particolarmente utili per la produzione di vaccini per il trattamento di malattie intestinali e simili e metodo di ingegneria genetica per la produzione dei detti vaccini
DE69024659D1 (de) Harnwegstumor-assoziiertes antigen, verwendung von antigenen untereinheiten und nachweisverfahren
ES2032447T3 (es) Nuevos anticuerpos monoclonales y su produccion y uso.
DE2964176D1 (en) Heteropolysaccharides produced by bacteria and derived products, their preparation, and the lyophilized culture of the bacteria
ATE136467T1 (de) Biologisches präparat und seine verwendung
AU2456888A (en) Monoclonal antibodies specific for HIV and hybridomas for their production
DE3850993D1 (de) Monoklonaler Antikörper spezifisch gegen humane Pankreas-Phospholipase-A2.
ATE108663T1 (de) Treponema hyodysenteriae-antigen und seine verwendungen.
EP0589348A3 (de) Verfahren zur immunchemischen Quantifizierung von inaktivierten, immunreaktiven Antigenen.
EP0345559A3 (en) Hiv-2 variants
DE3872437D1 (de) Verfahren zur gewinnung von insektenpathogenen proteinen und mikroorganismen des typs bacillus thuringiensis.
EP0314993A3 (de) 1,7,9,15-Tetraoxa-4,12-diaza-8-silaspiro-[7.7]-pentadecane, Verfahren zu ihrer Herstellung und ihre Verwendung
GB2093347B (en) Immunostimulant material tf-2 from fusobacterium sp
DE69124317D1 (de) Monoklonale Antikörper gegen Leptosphaeria
NO934572L (no) Fremgnagsmaate for fremstilling av rekombinante proteiner og de be nyt-tede verstsceller
FR2531863B1 (fr) Procede de preparation d'une substance ayant une activite carcinostatique et immunostimulante, a partir de micro-organismes du genre fusobacterium
NO843446L (no) Antibiotikum sb 22484
DK0441991T3 (da) DNA-sonde for Lactobacillus helveticus
Fedorov et al. Microbe treatment of sewage from benzaldehyde production. Obtaining of strains-destructors of the basic components.